보령 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 보령홀딩스, was filed 06 May 2026.
보령: what insiders have been doing
보령 belongs to the Health Care sector. Filings by its managers are published through DART (FSS). From 2 November 2025 to 2 November 2026, the disclosure feed for 보령 logged 10 filings by 5 insiders.
On the market, 2 insiders bought (3 purchases totalling €5.3M) while 2 insiders sold (2 sales). The totals do not cover 3 filings with an undisclosed amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €4.7M from 국민연금공단, disclosed on 1 April 2026, or 0.98% of market capitalisation.
Across the 2,655 companies tracked on its exchange, the median is 7 filings; at 10 filings, this issuer sits above that mark. Since 2021, the database holds 17 purchases and 2 sales by insiders of the company.
The last insider purchase was made public on 6 May 2026, 186 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 5 days. That lag is the time during which only the insider knows about the trade.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and UCB. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -14.0%Entry ₩9,660 · Close 30 Oct 2026 ₩8,310
- -8.1%Entry ₩9,040 · Close 30 Oct 2026 ₩8,310
- -7.3%Entry ₩9,730 · Close at T+365 ₩9,020
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- Other0DART
- Other0DART
- ●Executives0DART
- ●Executives0DART
- 18,097,207 sharesShareKRXDART:20260506000691
- 117,572 shares0.14% mcap100.0% of flowKRXDART:20260506000678Canonical exit: 29 Jul 2026 (T+90)
- 18,097,207 sharesShareKRXDART:20260506000682Canonical exit: 30 Jul 2026 (T+90)
- 860,038 shares0.98% mcap100.0% of flowKRXDART:20260401003037Canonical exit: 25 Jun 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 7,000 sharesShareKRXDART:20260219002161
- ●Executives0DART
- 4,737 sharesShareKRXDART:20250523000174Canonical exit: 21 Aug 2025 (T+90)
- 5,026 sharesShareKRXDART:20241205000203Canonical exit: 5 Mar 2025 (T+90)
- 18,097,207 sharesShareKRXDART:20241118000245Canonical exit: 16 Feb 2025 (T+90)
- 8,223,345 sharesKRXDART:20241118000235Canonical exit: 12 Feb 2025 (T+90)
- 12,259 sharesKRXDART:20240611000334Canonical exit: 7 Sept 2024 (T+90)
- 2,959 sharesShareKRXDART:20240108000552Canonical exit: 31 Mar 2024 (T+90)
- ShareKRXDART:20231010000430
- ShareKRXDART:20230724000229
- ShareKRXDART:20230712000487
- ShareKRXDART:20230711000080
- 12,259 sharesKRXDART:20230710000475Canonical exit: 4 Oct 2023 (T+90)
- 12,259 sharesKRXDART:20230614000315Canonical exit: 7 Sept 2023 (T+90)
- ●Executives0DART
25 of 52 declarations
About 보령
Boryung is a company in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
